CB2 cannabinoid receptor mediation of antinociception

Pain

Volumn 122, Issue 1-2, 2006, Pages 36-42

  Ibrahim, Mohab M ^a   Rude, Megan L ^b   Stagg, Nicola J ^b   Mata, Heriberto P ^a   Lai, Josephine ^a   Vanderah, Todd W ^a   Porreca, Frank ^a   Buckley, Nancy E ^c   Makriyannis, Alexandros ^d   Malan Jr , T Philip ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c CALIFORNIA STATE POLYTECHNIC UNIVERSITY   (United States)

^d NORTHEASTERN UNIVERSITY   (United States)

Author keywords

AM1241; Cannabinoid; CB2; Knockout; Nociception; Pain; WIN55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 (2 IODO 5 NITROBENZOYL) 1 (1 METHYL 2 PIPERIDINYLMETHYL)INDOLE; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; MORPHINE SULFATE; UNCLASSIFIED DRUG; ANALGESIC AGENT; CANNABINOID;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; FEMALE; GENE DISRUPTION; IN VIVO STUDY; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; THERMAL STIMULATION; WILD TYPE; ANIMAL; DRUG EFFECT; METABOLISM; PAIN ASSESSMENT; PAIN THRESHOLD; PATHOPHYSIOLOGY;

ANALGESICS; ANIMALS; CANNABINOIDS; MICE; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RECEPTOR, CANNABINOID, CB2;

EID: 33646062552     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2005.12.018     Document Type: Article

References (37)

1. Begg M., Pacher P., Batkai S., Osei-Hyiaman D., Offertaler L., Mo F.M., Liu J., and Kunos G. Evidence for novel cannabinoid receptors. Pharmacol Ther 106 (2005) 133-145
2. Bridges D., Ahmad K., and Rice A.S. The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. Br J Pharmacol 133 (2001) 586-594
3. Buckley N.E., McCoy K.L., Mezey E., Bonner E.T., Zimmer A., Felder C.C., et al. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur J Pharmacol 396 (2000) 141-149
4. Cichewicz D.L., and McCarthy E.A. Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration. J Pharmacol Exp Ther 304 (2003) 1010-1015
5. Clarke R.W., and Harris J. The organization of motor responses to noxious stimuli. Brain Res Brain Res Rev 46 (2004) 163-172
6. Dolin S.J., Cashman J.N., and Bland J.M. Effectiveness of acute postoperative pain management: I. Evidence from published data. Br J Anaesth 89 (2002) 409-423
7. Facci L., Dal Toso R., Romanello S., Buriani A., Skaper S.D., and Leon A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA 92 (1995) 3376-3380
8. Felder C.C., Joyce K.E., Briley E.M., Mansouri J., Mackie K., Blond O., et al. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48 (1995) 443-450
9. Fox A., Kesingland A., Gentry C., McNair K., Patel S., Urban L., et al. The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain 92 (2001) 91-100
10. 123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. Eur J Pharmacol 307 (1996) 331-338
11. Gatley S.J., Lan R., Pyatt B., Gifford A.N., Volkow N.D., and Makriyannis A. Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors. Life Sci 61 (1997) PL191-PL197
12. Gingrich J.A., and Hen R. The broken mouse: the role of development, plasticity and environment in the interpretation of phenotypic changes in knockout mice. Curr Opin Neurobiol 10 (2000) 146-152
13. Golech S.A., McCarron R.M., Chen Y., Bembry J., Lenz F., Mechoulam R., et al. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Brain Res Mol Brain Res 132 (2004) 87-92
14. Griffin G., Wray E.J., Tao Q., McAllister S.D., Rorrer W.K., Aung M.M., et al. Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system. Eur J Pharmacol 377 (1999) 117-125
15. Hájos N., Ledent C., and Freund T.F. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106 (2001) 1-4
16. Hanuš L., Breuer A., Tchilibon S., Shiloah S., Goldenberg D., Horowitz M., et al. HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. Proc Natl Acad Sci USA 96 (1999) 14228-14233
17. Hargreaves K.M., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
18. Herzberg U., Eliav E., Bennett G.J., and Kopin I.J. The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci Lett 221 (1997) 157-160
19. Hohmann A.G., Tsou K., and Walker J.M. Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat. J Neurophysiol 81 (1999) 575-583
20. 35S]GTPγ-S binding in the mouse brain. Eur J Pharmacol 321 (1997) R1-R3
21. 2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc Natl Acad Sci USA 100 (2003) 10529-10533
22. Jarai Z., Wagner J.A., Varga K., Lake K.D., Compton D.R., Martin B.R., et al. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci USA 96 (1999) 14136-14141
23. Jensen T.S., and Yaksh T.L. Comparison of antinociceptive action of morphine in the periaqueductal gray, medial and paramedial medulla in rat. Brain Res 363 (1986) 99-113
24. Kehl L.J., Hamamoto D.T., Wacnik P.W., Croft D.L., Norsted B.D., Wilcox G.L., et al. A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain. Pain 103 (2003) 175-186
25. 2 cannabinoid receptor-mediated peripheral antinociception. Pain 93 (2001) 239-245
26. Munro S., Thomas K.L., and Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 (1993) 61-65
27. Nackley A.G., Makriyannis A., and Hohmann A.G. Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Neuroscience 119 (2003) 747-757
28. 2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study. Synapse 53 (2004) 208-213
29. 2 cannabinoid receptors. Anesthesiology 99 (2003) 955-960
30. 2 cannabinoid receptors of L759633, L759656, and AM630. Br J Pharmacol 126 (1999) 665-672
31. Sage J., Miller A.L., Perez-Mancera P.A., Wysocki J.M., and Jacks T. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424 (2003) 223-228
32. Schatz A.R., Lee M., Condie R.B., Pulaski J.T., and Kaminski N.E. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol Appl Pharmacol 142 (1997) 278-287
33. Simoneau I.I., Hamza M.S., Mata H.P., Siegel E.M., Vanderah T.W., Porreca F., et al. The cannabinoid agonist WIN55,212-2 suppresses opioid-induced emesis in ferrets. Anesthesiology 94 (2001) 882-887
34. Song Z.H., Slowey C.A., Hurst D.P., and Reggio P.H. The difference between the CB(1) and CB(2) cannabinoid receptors at position 5.46 is crucial for the selectivity of WIN55212-2 for CB(2). Mol Pharmacol 56 (1999) 834-840
35. 2 receptors. Science 310 (2005) 329-332
36. Zimmer A., Zimmer A.M., Hohmann A.G., Herkenham M., and Bonner T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA 96 (1999) 5780-5785
37. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110